A new treatment for endometrial cancer with gonadotrophin releasing‐hormone analogue
- 1 October 1991
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 98 (10), 1037-1041
- https://doi.org/10.1111/j.1471-0528.1991.tb15343.x
Abstract
Objective— To test the antitumour effect of gonadotrophin releasing-hormone (GnRH) analogues in women with recurrent endometrial cancer. Design— An open phase II observational trial of GnRH analogues. Serial measurements of gonadotrophins, sex hormones and tumour dimensions were made together with repeat biopsy when possible to assess the response to treatment. Setting— The outpatient clinics of the Department of Medical Oncology at The Royal London, Royal Marsden and St Bartholomew's hospitals. Subjects— 17 patients with endometrial cancer which had recurred after surgery, radiotherapy and progesterone treatment and was symptomatic, progressive and assessable for response. Intervention— Monthly subcutaneous injection of GnRH analogue. Main outcome measures— Reduction in serum gonadotrophins and reduction in tumour dimensions. Results— Six out of 17 patients (35%, 95% CI 12.6–58%) achieved a complete or partial remission which continues for a median of 20 months with no adverse effects. Conclusion— GnRH analogues have a significant antitumour effect in recurrent endometrial cancer which warrants further examination in comparison with progestogens.Keywords
This publication has 27 references indexed in Scilit:
- Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: Analysis of prognostic and treatment-related factorsGynecologic Oncology, 1989
- 426 Cases of stage I endometrial carcinoma: A clinicopathological analysisGynecologic Oncology, 1989
- Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancerBMJ, 1988
- Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: A Southwest Oncology Group studyGynecologic Oncology, 1987
- Melphalan, 5-Fluorouracil, and Medroxyprogesterone Acetate in Metastatic Endometrial CarcinomaObstetrics & Gynecology, 1986
- Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistNature, 1985
- Specific binding of luteinizing hormone releasing hormone to human luteal tissueBiochemical and Biophysical Research Communications, 1983
- Treatment of Advanced Endometrial Carcinoma with TamoxifenNew England Journal of Medicine, 1979
- The treatment of advanced endometrial cancer with hydroxyprogesterone caproateGynecologic Oncology, 1974
- Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase methodBiochemical and Biophysical Research Communications, 1971